Ray Lockard
Chief Tech/Sci/R&D Officer at TSCAN THERAPEUTICS, INC.
Ray Lockard active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-04-05 | - |
Career history of Ray Lockard
Former positions of Ray Lockard
| Companies | Position | Start | End |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 2020-10-31 | 2021-11-30 |
| AVEXIS INC | Corporate Officer/Principal | 2018-12-31 | 2020-09-30 |
Training of Ray Lockard
| Hampden-Sydney College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Ray Lockard
- Experience
